CHRNA4 and Cognitive impairment: However, future choices of the appropriate nAChR subtype(s) or subunit(s) as the therapeutic target for each particular form of cognitive impairment will require a much more detailed understanding of the nature of the individual diseases and their underlying mechanisms, especially with respect to the involvement of nAChRs.